-
pbrn.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
January 31, 2024 - best practices and that included simple
messages, at accessible reading levels (no higher than 6th grade
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
January 31, 2024 - best practices and that included simple
messages, at accessible reading levels (no higher than 6th grade
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
January 31, 2024 - best practices and that included simple
messages, at accessible reading levels (no higher than 6th grade
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
July 01, 2024 - best practices and that included simple
messages, at accessible reading levels (no higher than 6th grade
-
www.cpsi.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
-
ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2015qdr-chartbookblacks.pptx
February 09, 2016 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - 70.95
Multi organ failure:
2/495, 0/479
RR = 4.83; CI: 0.23 to
100.13
Guillain-Barre
Syndrome Grade
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - 70.95
Multi organ failure:
2/495, 0/479
RR = 4.83; CI: 0.23 to
100.13
Guillain-Barre
Syndrome Grade
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
January 01, 2016 - Pathways Community HUB Manual
A
Pathways Community
HUB Manual
A Guide to Identify and Address Risk Factors,
Reduce Costs, and Improve Outcomes
Pathways Community
HUB Manual
A Guide to Identify and Address Risk Factors,
Reduce Costs, and Improve Outcomes
Prepared for:
Agency for Healthcare Research and Qua…
-
www.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
January 01, 2016 - Pathways Community HUB Manual
A
Pathways Community
HUB Manual
A Guide to Identify and Address Risk Factors,
Reduce Costs, and Improve Outcomes
Pathways Community
HUB Manual
A Guide to Identify and Address Risk Factors,
Reduce Costs, and Improve Outcomes
Prepared for:
Agency for Healthcare Research and Qua…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment
Methods Guide
for Comparative Effectiveness Reviews
Guidance for the Conduct and Reporting of Modeling
and Simulation Studies in the Context of Health
Technology Assessment
Th…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment
Methods Guide
for Comparative Effectiveness Reviews
Guidance for the Conduct and Reporting of Modeling
and Simulation Studies in the Context of Health
Technology Assessment
Th…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
July 20, 2021 - Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Screening for Colorectal Cancer
Updated Evidence Report and Systematic Review
for the US Preventive Services Task Force
Jennifer S. Lin, MD; Leslie A. Perdue, MPH; Nora B. Henrikson, PhD; Sarah I. …
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third and final surveillance report for the Agency for Healthcare Research
an…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third and final surveillance report for the Agency for Healthcare Research
an…